Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

arachidonyl-2-chloroethylamide

Known as: ACEA cpd, N-(2-chloroethyl)-5,8,11,14-eicosatetraenamide, arachidonyl-2'-chloroethylamide 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Arachidonic Acids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Effects of in vitro antagonism of endocannabinoid‐1 receptors on the glucose transport system in normal and insulin‐resistant rat skeletal muscle
Objective: We determined the direct effects of modulating the endocannabinoid‐1 (CB1) receptor on the glucose transport system in… Expand
2009
2009
Endogenous cannabinoids induce fever through the activation of CB1 receptors
Background and purpose:  The effects of centrally administered cannabinoids on body core temperature (Tc) and the contribution of… Expand
Highly Cited
2007
Highly Cited
2007
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties
We have recently demonstrated that two plant-derived cannabinoids, Delta9-tetrahydrocannabinol and cannabidiol (CBD), are… Expand
Highly Cited
2006
Highly Cited
2006
Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
Endogenous cannabinoid ligands and cannabinoid CB(1) receptor agonists have been shown to exert potent anticonvulsant effects in… Expand
Highly Cited
2006
Highly Cited
2006
Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.
Recent reports have described the presence of cannabinoid CB1 receptors in pancreatic islets. Here we show that administration of… Expand
2006
2006
ACEA (arachidonyl-2-chloroethylamide), the selective cannabinoid CB1 receptor agonist, protects against aspirin-induced gastric ulceration.
The effect of a selective cannabinoid CB1 receptor agonist, ACEA (arachidonyl-2-chloroethylamide) in an aspirin-induced ulcer… Expand
Highly Cited
2004
Highly Cited
2004
Modulation of trigeminal sensory neuron activity by the dual cannabinoid–vanilloid agonists anandamide, N‐arachidonoyl‐dopamine and arachidonyl‐2‐chloroethylamide
Peripheral cannabinoids have been shown to suppress nociceptive neurotransmission in a number of behavioral and… Expand
2004
2004
The cannabinomimetic arachidonyl‐2‐chloroethylamide (ACEA) acts on capsaicin‐sensitive TRPV1 receptors but not cannabinoid receptors in rat joints
The vasoactive effects of the synthetic cannabinoid (CB) arachidonyl‐2‐chloroethylamide (ACEA) was tested in the knee joints of… Expand
2004
2004
Antidepressant--like properties of ACEA (arachidonyl-2-chloroethylamide), the selective agonist of CB1 receptors.
The antidepressant effect of ACEA (arachidonyl-2-chloroethylamide), a selective agonist of CB1 receptors, and its interaction… Expand
Highly Cited
1999
Highly Cited
1999
Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1).
Two subtypes of the cannabinoid receptor (CB1 and CB2) are expressed in mammalian tissues. Although selective antagonists are… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE